Modeling and Simulation in Clinical Pharmacology and Dose Finding-Reference-Cited by-同舟云学术

Modeling and Simulation in Clinical Pharmacology and Dose Finding

Published:2013-02 Issue:2 Volume:2 Page:29
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Staab A¹,Rook E²³,Maliepaard M²³,Aarons L⁴,Benson C⁵

Affiliation:

1. Translational Medicine, Pharmacometrics, Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach Germany

2. Medicines Evaluation Board, Graadt van Roggenweg; Utrecht The Netherlands

3. European Medicines Agency; London UK

4. School of Pharmacy and Pharmaceutical Sciences, The University of Manchester; Manchester UK

5. Eli Lilly, Lilly Corporate Center; Indianapolis Indiana USA

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2013.5/fullpdf

Reference10 articles.

1. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry;Stone;J. Clin. Pharmacol.,2010

2. Model-based drug development;Lalonde;Clin. Pharmacol. Ther.,2007

3. Role of modelling and simulation: a European regulatory perspective;Jönsson;Clin. Pharmacokinet.,2012

4. Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008;Lee;Clin. Pharmacokinet.,2011

5. European Medicines Agency Draft concept paper: Concept paper on extrapolation of efficacy and safety in medicine development http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129285.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein;The Journal of Clinical Pharmacology;2022-12

2. Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities;Clinical Pharmacology & Therapeutics;2021-12-20

3. The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia;Pharmaceutics;2021-04-22

4. Manipulating the Mediator complex to induce naïve pluripotency;Experimental Cell Research;2020-10

5. Model-based simulation to support the extended dosing regimens of atezolizumab;European Journal of Clinical Pharmacology;2020-08-17